Kate R Secombe

7PUBLICATIONS
3CO-AUTHORS
Molecular targetsMedical infection agents (incl. prions)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Oct 27, 2022
Gut Microbiota-Derived Short-Chain Fatty Acids: Impact on Cancer Treatment Response and Toxicities.

Ghanyah H Al-Qadami, Kate R Secombe, Courtney B Subramaniam

|Dec 02, 2021
Intestinal toll-like receptor 4 knockout alters the functional capacity of the gut microbiome following irinotecan treatment.

Kate R Secombe, Elise E Crame, Janine S Y Tam

|Jul 20, 2020
Pathophysiology of neratinib-induced diarrhea in male and female rats: microbial alterations a potential determinant.

Kate R Secombe, Imogen A Ball, Joseph Shirren

|Jun 05, 2020
Diarrhea Induced by Small Molecule Tyrosine Kinase Inhibitors Compared With Chemotherapy: Potential Role of the Microbiome.

Kate R Secombe, Ysabella Z A Van Sebille, Bronwen J Mayo

|Dec 12, 2018
Targeting neratinib-induced diarrhea with budesonide and colesevelam in a rat model.

Kate R Secombe, Imogen A Ball, Joseph Shirren

Pageof 2